0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Topotecan Market Research Report 2023
Published Date: April 2023
|
Report Code: QYRE-Auto-19Z5878
Home | Market Reports | Science| Biological Sciences
Global Topotecan Market Insights and Forecast to 2028
BUY CHAPTERS

Global Topotecan Market Research Report 2023

Code: QYRE-Auto-19Z5878
Report
April 2023
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Topotecan Market

Topotecan (trade name Hycamtin) is a chemotherapeutic agent that is a topoisomerase inhibitor. It is a synthetic, water-soluble analog of the natural chemical compound camptothecin. It is used in the form of its hydrochloride salt to treat ovarian cancer, lung cancer and other cancer types.
The global Topotecan market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Topotecan is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Topotecan is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Topotecan in Ovarian Cancer is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Topotecan include GSK, Teva, Fresenius Kabi, Cipla, Sagent Pharmaceuticals, Mylan, Pfizer and Dr. Reddy's Laboratories, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Topotecan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Topotecan.
The Topotecan market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Topotecan market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Topotecan companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Global Topotecan Market Report

Report MetricDetails
Report NameGlobal Topotecan Market
Base Year2022
Forecasted years2023-2029
By Company
  • GSK
  • Teva
  • Fresenius Kabi
  • Cipla
  • Sagent Pharmaceuticals
  • Mylan
  • Pfizer
  • Dr. Reddy's Laboratories
Segment by Type
  • Capsules
  • Injection
Segment by Application
  • Ovarian Cancer
  • Lung Cancer
  • Other Cancer types
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
Forecast unitsUSD million in value
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Topotecan companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Topotecan Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Capsules
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Topotecan Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Ovarian Cancer
1.3.3 Lung Cancer
1.3.4 Other Cancer types
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Topotecan Market Perspective (2018-2029)
2.2 Topotecan Growth Trends by Region
2.2.1 Global Topotecan Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Topotecan Historic Market Size by Region (2018-2023)
2.2.3 Topotecan Forecasted Market Size by Region (2024-2029)
2.3 Topotecan Market Dynamics
2.3.1 Topotecan Industry Trends
2.3.2 Topotecan Market Drivers
2.3.3 Topotecan Market Challenges
2.3.4 Topotecan Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Topotecan Players by Revenue
3.1.1 Global Top Topotecan Players by Revenue (2018-2023)
3.1.2 Global Topotecan Revenue Market Share by Players (2018-2023)
3.2 Global Topotecan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Topotecan Revenue
3.4 Global Topotecan Market Concentration Ratio
3.4.1 Global Topotecan Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Topotecan Revenue in 2022
3.5 Topotecan Key Players Head office and Area Served
3.6 Key Players Topotecan Product Solution and Service
3.7 Date of Enter into Topotecan Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Topotecan Breakdown Data by Type
4.1 Global Topotecan Historic Market Size by Type (2018-2023)
4.2 Global Topotecan Forecasted Market Size by Type (2024-2029)
5 Topotecan Breakdown Data by Application
5.1 Global Topotecan Historic Market Size by Application (2018-2023)
5.2 Global Topotecan Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Topotecan Market Size (2018-2029)
6.2 North America Topotecan Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Topotecan Market Size by Country (2018-2023)
6.4 North America Topotecan Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Topotecan Market Size (2018-2029)
7.2 Europe Topotecan Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Topotecan Market Size by Country (2018-2023)
7.4 Europe Topotecan Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Topotecan Market Size (2018-2029)
8.2 Asia-Pacific Topotecan Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Topotecan Market Size by Region (2018-2023)
8.4 Asia-Pacific Topotecan Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Topotecan Market Size (2018-2029)
9.2 Latin America Topotecan Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Topotecan Market Size by Country (2018-2023)
9.4 Latin America Topotecan Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Topotecan Market Size (2018-2029)
10.2 Middle East & Africa Topotecan Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Topotecan Market Size by Country (2018-2023)
10.4 Middle East & Africa Topotecan Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Topotecan Introduction
11.1.4 GSK Revenue in Topotecan Business (2018-2023)
11.1.5 GSK Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Topotecan Introduction
11.2.4 Teva Revenue in Topotecan Business (2018-2023)
11.2.5 Teva Recent Development
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Detail
11.3.2 Fresenius Kabi Business Overview
11.3.3 Fresenius Kabi Topotecan Introduction
11.3.4 Fresenius Kabi Revenue in Topotecan Business (2018-2023)
11.3.5 Fresenius Kabi Recent Development
11.4 Cipla
11.4.1 Cipla Company Detail
11.4.2 Cipla Business Overview
11.4.3 Cipla Topotecan Introduction
11.4.4 Cipla Revenue in Topotecan Business (2018-2023)
11.4.5 Cipla Recent Development
11.5 Sagent Pharmaceuticals
11.5.1 Sagent Pharmaceuticals Company Detail
11.5.2 Sagent Pharmaceuticals Business Overview
11.5.3 Sagent Pharmaceuticals Topotecan Introduction
11.5.4 Sagent Pharmaceuticals Revenue in Topotecan Business (2018-2023)
11.5.5 Sagent Pharmaceuticals Recent Development
11.6 Mylan
11.6.1 Mylan Company Detail
11.6.2 Mylan Business Overview
11.6.3 Mylan Topotecan Introduction
11.6.4 Mylan Revenue in Topotecan Business (2018-2023)
11.6.5 Mylan Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Topotecan Introduction
11.7.4 Pfizer Revenue in Topotecan Business (2018-2023)
11.7.5 Pfizer Recent Development
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Detail
11.8.2 Dr. Reddy's Laboratories Business Overview
11.8.3 Dr. Reddy's Laboratories Topotecan Introduction
11.8.4 Dr. Reddy's Laboratories Revenue in Topotecan Business (2018-2023)
11.8.5 Dr. Reddy's Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Topotecan Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Capsules
    Table 3. Key Players of Injection
    Table 4. Global Topotecan Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global Topotecan Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Topotecan Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Topotecan Market Share by Region (2018-2023)
    Table 8. Global Topotecan Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Topotecan Market Share by Region (2024-2029)
    Table 10. Topotecan Market Trends
    Table 11. Topotecan Market Drivers
    Table 12. Topotecan Market Challenges
    Table 13. Topotecan Market Restraints
    Table 14. Global Topotecan Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Topotecan Market Share by Players (2018-2023)
    Table 16. Global Top Topotecan Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Topotecan as of 2022)
    Table 17. Ranking of Global Top Topotecan Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by Topotecan Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Topotecan Product Solution and Service
    Table 21. Date of Enter into Topotecan Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Topotecan Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Topotecan Revenue Market Share by Type (2018-2023)
    Table 25. Global Topotecan Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Topotecan Revenue Market Share by Type (2024-2029)
    Table 27. Global Topotecan Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Topotecan Revenue Market Share by Application (2018-2023)
    Table 29. Global Topotecan Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Topotecan Revenue Market Share by Application (2024-2029)
    Table 31. North America Topotecan Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America Topotecan Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America Topotecan Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe Topotecan Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe Topotecan Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe Topotecan Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific Topotecan Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific Topotecan Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific Topotecan Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Topotecan Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America Topotecan Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America Topotecan Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa Topotecan Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa Topotecan Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa Topotecan Market Size by Country (2024-2029) & (US$ Million)
    Table 46. GSK Company Detail
    Table 47. GSK Business Overview
    Table 48. GSK Topotecan Product
    Table 49. GSK Revenue in Topotecan Business (2018-2023) & (US$ Million)
    Table 50. GSK Recent Development
    Table 51. Teva Company Detail
    Table 52. Teva Business Overview
    Table 53. Teva Topotecan Product
    Table 54. Teva Revenue in Topotecan Business (2018-2023) & (US$ Million)
    Table 55. Teva Recent Development
    Table 56. Fresenius Kabi Company Detail
    Table 57. Fresenius Kabi Business Overview
    Table 58. Fresenius Kabi Topotecan Product
    Table 59. Fresenius Kabi Revenue in Topotecan Business (2018-2023) & (US$ Million)
    Table 60. Fresenius Kabi Recent Development
    Table 61. Cipla Company Detail
    Table 62. Cipla Business Overview
    Table 63. Cipla Topotecan Product
    Table 64. Cipla Revenue in Topotecan Business (2018-2023) & (US$ Million)
    Table 65. Cipla Recent Development
    Table 66. Sagent Pharmaceuticals Company Detail
    Table 67. Sagent Pharmaceuticals Business Overview
    Table 68. Sagent Pharmaceuticals Topotecan Product
    Table 69. Sagent Pharmaceuticals Revenue in Topotecan Business (2018-2023) & (US$ Million)
    Table 70. Sagent Pharmaceuticals Recent Development
    Table 71. Mylan Company Detail
    Table 72. Mylan Business Overview
    Table 73. Mylan Topotecan Product
    Table 74. Mylan Revenue in Topotecan Business (2018-2023) & (US$ Million)
    Table 75. Mylan Recent Development
    Table 76. Pfizer Company Detail
    Table 77. Pfizer Business Overview
    Table 78. Pfizer Topotecan Product
    Table 79. Pfizer Revenue in Topotecan Business (2018-2023) & (US$ Million)
    Table 80. Pfizer Recent Development
    Table 81. Dr. Reddy's Laboratories Company Detail
    Table 82. Dr. Reddy's Laboratories Business Overview
    Table 83. Dr. Reddy's Laboratories Topotecan Product
    Table 84. Dr. Reddy's Laboratories Revenue in Topotecan Business (2018-2023) & (US$ Million)
    Table 85. Dr. Reddy's Laboratories Recent Development
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Topotecan Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Topotecan Market Share by Type: 2022 VS 2029
    Figure 3. Capsules Features
    Figure 4. Injection Features
    Figure 5. Global Topotecan Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 6. Global Topotecan Market Share by Application: 2022 VS 2029
    Figure 7. Ovarian Cancer Case Studies
    Figure 8. Lung Cancer Case Studies
    Figure 9. Other Cancer types Case Studies
    Figure 10. Topotecan Report Years Considered
    Figure 11. Global Topotecan Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 12. Global Topotecan Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Topotecan Market Share by Region: 2022 VS 2029
    Figure 14. Global Topotecan Market Share by Players in 2022
    Figure 15. Global Top Topotecan Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Topotecan as of 2022)
    Figure 16. The Top 10 and 5 Players Market Share by Topotecan Revenue in 2022
    Figure 17. North America Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 18. North America Topotecan Market Share by Country (2018-2029)
    Figure 19. United States Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Canada Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Topotecan Market Share by Country (2018-2029)
    Figure 23. Germany Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. France Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. U.K. Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Italy Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Russia Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Nordic Countries Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Topotecan Market Share by Region (2018-2029)
    Figure 31. China Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Japan Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. South Korea Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Southeast Asia Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. India Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Australia Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Topotecan Market Share by Country (2018-2029)
    Figure 39. Mexico Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Brazil Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Topotecan Market Share by Country (2018-2029)
    Figure 43. Turkey Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Saudi Arabia Topotecan Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. GSK Revenue Growth Rate in Topotecan Business (2018-2023)
    Figure 46. Teva Revenue Growth Rate in Topotecan Business (2018-2023)
    Figure 47. Fresenius Kabi Revenue Growth Rate in Topotecan Business (2018-2023)
    Figure 48. Cipla Revenue Growth Rate in Topotecan Business (2018-2023)
    Figure 49. Sagent Pharmaceuticals Revenue Growth Rate in Topotecan Business (2018-2023)
    Figure 50. Mylan Revenue Growth Rate in Topotecan Business (2018-2023)
    Figure 51. Pfizer Revenue Growth Rate in Topotecan Business (2018-2023)
    Figure 52. Dr. Reddy's Laboratories Revenue Growth Rate in Topotecan Business (2018-2023)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Nucleic Acid Detection Equipment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-26R7590
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Protein A Agarose Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-12Z7679
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Isopropyl-β-D-Thiogalactoside (IPTG) Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-21O7667
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Microbiome Therapies Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-10Q13501
Fri Feb 23 00:00:00 UTC 2024

Add to Cart